AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19552097
Drug: Metformin 500mg
RxNorm normalized name: METFORMIN 500MG/SITAGLIPTIN 50MG TAB
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin 500mg orally 8 hourly daily for initial 3 months, followed by clomiphene 50mg orally once daily for 5 days for subsequent 3 months
Trial: 19552097
Drug: Placebo (folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (folic acid 5mg orally once daily for initial 3 months), followed by clomiphene 50mg orally once daily for 5 days for subsequent 3 months
Trial: 11148694
Drug: Microchips and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microchips and heat sensors for compliance with amblyopia therapy
Trial: 9350166
Drug: Moderate beer
RxNorm normalized name: BEER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate beer consumption (330 ml of Maccabee beer, > 20 g of alcohol) for 30 consecutive days
Trial: 31615726
Drug: Unpreserved trehalose
RxNorm normalized name: Trehalose
DrugBank: Trehalose (DB12310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unpreserved trehalose 3%, hyaluronic acid 0.15%, carbomer 0.25% (THHA, Thealoz Duo Gel)
Trial: 30285758
Drug: internet delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: internet delivered cognitive behaviour therapy (iCBT) plus treatment as usual (TAU)
Trial: 27180023
Drug: Midazolam (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.04 mg/kg) and propofol (1.0 μg/mL)
Trial: 27180023
Drug: Propofol (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (1.5 μg/mL)
Trial: 24630053
Drug: Randomized treatment
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized treatment assignment
Trial: 20724140
Drug: 5FU, folinic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5FU, folinic acid and cisplatin combination followed by gemcitabine (Arm A)
Trial: 20724140
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment arms (Arm A and Arm B)
Trial: 16167420
Drug: Clindamycin/benzoyl peroxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin/benzoyl peroxide gel (combination formulation)
Trial: 16167420
Drug: Clindamycin/benzoyl peroxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin/benzoyl peroxide gel + tretinoin gel + clindamycin gel
Trial: 16167420
Drug: Clindamycin/benzoyl peroxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin/benzoyl peroxide gel
Trial: 12934183
Drug: Virosome-formulated, aluminum-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virosome-formulated, aluminum-free inactivated HAV vaccine
Trial: 30463813
Drug: atorvastatin group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atorvastatin group
Trial: 22129843
Drug: Psilocybin 5
RxNorm normalized name: Psilocybin
DrugBank: Psilocybin (DB11664)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psilocybin 5 mg/70 kg
Trial: 22129843
Drug: Psilocybin 10
RxNorm normalized name: Psilocybin
DrugBank: Psilocybin (DB11664)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psilocybin 10 mg/70 kg
Trial: 22129843
Drug: Psilocybin 0
RxNorm normalized name: Psilocybin
DrugBank: Psilocybin (DB11664)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psilocybin 0 mg/70 kg (placebo)
Trial: 16643550
Drug: Subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous sumatriptan 3 mg (1 mL)
Trial: 12893646
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 800 microg BUD via Turbuhaler
Trial: 12893646
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 750 microg FP via Diskus
Trial: 12893646
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 200 microg BUD
Trial: 12893646
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 200 microg fluticasone dipropionate
Trial: 12893646
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of BUD and FP on the same day
Trial: 1552406
Drug: Depakote Sprinkle
RxNorm normalized name: Depakote Sprinkles
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Depakote Sprinkle capsules
Trial: 1552406
Drug: Depakene syrup
RxNorm normalized name: Depakote
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Depakene syrup
Trial: 22706026
Drug: Trans-triepitopic antibody
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trans-triepitopic antibody fusions
Trial: 20331585
Drug: Lymphocyte immunotherapy
RxNorm normalized name: Therapeutic allogeneic lymphocytes
DrugBank: Therapeutic allogeneic lymphocytes (DB17459)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lymphocyte immunotherapy
Trial: 18558169
Drug: Ceftriaxone and
RxNorm normalized name: Ceftriaxone and sulbactam only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone and metronidazole (CM) - 2 total doses per day
Trial: 18558169
Drug: Ampicillin, gentamicin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin, gentamicin, and clindamycin (AGC) - 11 total doses per day
Trial: 6151243
Drug: Trimipramine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimipramine (various doses)
Trial: 6151243
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg trimipramine in the evening
Trial: 24088617
Drug: Weight Management
RxNorm normalized name: Estroven Weight Management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight Management (WM) intervention including education about regular daily weight monitoring and coping skills, with a WM booklet and scheduled telephone visits
Trial: 19874314
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injections at the temporal hairline
Trial: 19874314
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injections at the temporal hairline plus extra injections at each temporal line
Trial: 18037223
Drug: Epo‐alpha (40,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epo‐alpha (40,000 IU intravenously each injection, 5 doses within 48 hours)
Trial: 11069340
Drug: Alfentanil 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 0.25 mg with bupivacaine 2.5 mg intrathecally
Trial: 11069340
Drug: Alfentanil 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 0.25 mg intrathecally
Trial: 8627434
Drug: Indomethacin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (0.1 mg/kg per dose, administered less than 24 hours after birth and again every 24 hours for six doses)
Trial: 4051254
Drug: Blood transfusion
RxNorm normalized name: Blood transfusion, auxiliary products
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood transfusion at a speed of 2 ml/min (Group A)
Trial: 4051254
Drug: Blood transfusion
RxNorm normalized name: Blood transfusion, auxiliary products
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood transfusion at a speed of 5 ml/min (Group B)
Trial: 31225739
Drug: Higher protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher protein pasta (10 g protein/serving)
Trial: 31225739
Drug: Regular pasta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular pasta (7 g protein/serving)
Trial: 27824398
Drug: Quercetin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin (1 g daily for 12 weeks)
Trial: 22085343
Drug: Extended-release niacin
RxNorm normalized name: niacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release niacin (1500 to 2000 mg per day)
Trial: 15042477
Drug: Antipsychotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic treatment with conventional, new atypical or depot neuroleptics
Trial: 15042477
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with conventional and depot neuroleptics
Trial: 15042477
Drug: Clozapine or
RxNorm normalized name: clozapine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine or combination treatment with conventional and atypical neuroleptics
Trial: 11755553
Drug: Transdermal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormone replacement therapy (HRT) with 17 beta-estradiol patches plus oral medroxyprogesterone acetate for 12 cycles of 28 days (group A)
Trial: 9416252
Drug: Continuous lumbar
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous lumbar epidural block with morphine
Trial: 8440099
Drug: CB0006 (anti-TNF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CB0006 (anti-TNF monoclonal antibody) at various doses (0.1 mg/kg, 1.0 mg/kg, 10 mg/kg, or two doses of 1 mg/kg 24 hrs apart)
Trial: 8440099
Drug: CB0006 (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CB0006 (high dose anti-TNF monoclonal antibody)
Trial: 8440099
Drug: Standard supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard supportive care and antimicrobial therapy
Trial: 3500735
Drug: Propofol 2.0‐2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2.0‐2.5 mg kg‐1
Trial: 3500735
Drug: Thiopentone 4‐5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 4‐5 mg kg‐1
Trial: 29324496
Drug: Ultrasound-guided serratus
RxNorm normalized name: Fucus serratus extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided serratus plane block with 0.4 mL/kg of 0.375% ropivacaine
Trial: 12663707
Drug: Interferon alfa-NL
RxNorm normalized name: Interferon Alfa-2A
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa-NL (Wellferon) given daily for 5 days every 3 weeks for up to 12 cycles
Trial: 8653161
Drug: Intramuscular ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular ketorolac (administered 3.5 hours before procedure)
Trial: 30730860
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rectal indomethacin and topical spray of epinephrine
Trial: 29034576
Drug: 5-g curcumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-g curcumin
Trial: 26627366
Drug: Clonazepam plus
RxNorm normalized name: Clonazepam
DrugBank: Clonazepam (DB01068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonazepam plus levetiracetam (2.5 g)
Trial: 24930819
Drug: Mindfulness meditation
RxNorm normalized name: benzalkonium chloride Topical Foam [Meditize]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness meditation intervention (daily practice during Asian history course)
Trial: 18165936
Drug: Methylcellulose pills
RxNorm normalized name: methylcellulose Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylcellulose pills (2-week supply), told it was a cognitive enhancer
Trial: 18165936
Drug: No pills
RxNorm normalized name: No Doz Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pills (control group)
Trial: 25944628
Drug: Fasting serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting serum insulin
Trial: 8205270
Drug: Fasting serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting serum insulin in Apo E 3/2 individuals
Trial: 8205270
Drug: Fasting serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting serum insulin overall
Trial: 11495173
Drug: Weight control
RxNorm normalized name: Daily-Vite Weight Control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight control plus cognitive behavioral body image therapy
Trial: 31560382
Drug: Daily low-quantity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily low-quantity drinking
Trial: 30600956
Drug: Antihistamines and
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihistamines and atorvastatin
Trial: 30600956
Drug: Antihistamines and
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihistamines and placebo
Trial: 25350130
Drug: TFV 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TFV 1% gel (40 mg TFV per 4 ml gel application)
Trial: 25350130
Drug: Oral TDF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral TDF (300 mg)
Trial: 25350130
Drug: Hydroxyethyl‐cellulose (HEC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl‐cellulose (HEC) placebo gel
Trial: 22035157
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg weekly (QW)
Trial: 12366624
Drug: Preoperative supraphysiological
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative supraphysiological testosterone (600 mg T enanthate intramuscularly weekly for 4 weeks)
Trial: 10404843
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 to 40 mg)
Trial: 2119796
Drug: Preoperative administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative administration of fenbufen
Trial: 29251360
Drug: Therapeutic INR
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic INR on warfarin
Trial: 29251360
Drug: Subtherapeutic INR
RxNorm normalized name: Inrebic
DrugBank: Fedratinib (DB12500)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Subtherapeutic INR on warfarin
Trial: 22429908
Drug: No anticoagulants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anticoagulants
Trial: 15286095
Drug: BIA 2-093
RxNorm normalized name: Oatmeal 10 mg in 1 mL TOPICAL CREAM [BIA Eczema Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIA 2-093 (200 mg bid)
Trial: 15286095
Drug: BIA 2-093
RxNorm normalized name: Oatmeal 10 mg in 1 mL TOPICAL CREAM [BIA Eczema Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIA 2-093 (400 mg qd)
Trial: 15286095
Drug: BIA 2-093
RxNorm normalized name: Oatmeal 10 mg in 1 mL TOPICAL CREAM [BIA Eczema Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIA 2-093 (800 mg qd)
Trial: 15286095
Drug: BIA 2-093
RxNorm normalized name: Oatmeal 10 mg in 1 mL TOPICAL CREAM [BIA Eczema Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIA 2-093 (1200 mg qd)
Trial: 8030593
Drug: Resistance training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance training with a diet providing 0.8 g protein.kg‐1.d‐1
Trial: 8030593
Drug: Resistance training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance training with a diet providing 1.6 g protein.kg‐1.d‐1
Trial: 2645063
Drug: Metoprolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (200 mg b.i.d.)
Trial: 28978332
Drug: Combination securement-dressing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination securement-dressing (CSD)
Trial: 12701975
Drug: IV ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV ketoprofen (100 mg)
Trial: 9295178
Drug: 0.125 mg
RxNorm normalized name: digoxin 0.125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125 mg Pergolide at bedtime
Trial: 9295178
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg L-Dopa + Carbidopa
Trial: 3080935
Drug: Transdermal nitroglycerin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin, 60 mg/24 h
Trial: 28681394
Drug: Amenamevir 400
RxNorm normalized name: amenamevir
DrugBank: Amenamevir (DB11701)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Amenamevir 400 mg
Trial: 28681394
Drug: Amenamevir 200
RxNorm normalized name: amenamevir
DrugBank: Amenamevir (DB11701)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Amenamevir 200 mg
Trial: 28681394
Drug: Valaciclovir 1000
RxNorm normalized name: valacyclovir 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 1000 mg three times daily (control)
Trial: 25835379
Drug: TiF4 gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TiF4 gel
Trial: 25835379
Drug: TiF4 gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TiF4 gel + CO2 laser
Trial: 25835379
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel + CO2 laser
Trial: 19727018
Drug: Creatine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine (5 g of Cr + 15 g maltodextrin, 4 times a day for 5 days)
Trial: 19727018
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 g maltodextrin, 4 times a day for 5 days)
Trial: 18278530
Drug: Subcutaneous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous ketamine treatment
Trial: 10774786
Drug: Molsidomine 12
RxNorm normalized name: molsidomine
DrugBank: Molsidomine (DB09282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine 12 mg orally for 48 hours
Trial: 6402000
Drug: Dazoxiben 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dazoxiben 200 mg four times daily
Trial: 22545088
Drug: ziprasidone (40-160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ziprasidone (40-160 mg/d)
Trial: 20731496
Drug: Enhanced Outpatient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced Outpatient Treatment (EOT)
Trial: 30971215
Drug: Continuing drug
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuing drug treatment with ChEIs (with or without memantine)
Trial: 30971215
Drug: Discontinuing drug
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuing drug treatment
Trial: 21883424
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel with triester glycerol oxide (TGO)
Trial: 21883424
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel without triester glycerol oxide (placebo)
Trial: 15699240
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (20 mg daily for 14 days)
Trial: 1853145
Drug: Nocloprost (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nocloprost (100 micrograms/dose)
Trial: 1853145
Drug: Aspirin (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (2.5 g)
Trial: 6348577
Drug: Preliminary volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preliminary volume expansion, vasodilators, and centrally acting drugs
Trial: 6348577
Drug: Classical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classical treatment for hypertension with a diuretic
Trial: 30897031
Drug: Hypoxic CHO
RxNorm normalized name: Hypoxis hemerocallidea root extract
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoxic CHO (HCHO; 6% CHO provided as 2 ml/kg/15 min; FiO2 = 16.3%)
Trial: 20355225
Drug: Measurement of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measurement of insulin-like growth factor-I (IGF-I) and type III pro-collagen (P-III-P) as markers of GH action
Trial: 17088488
Drug: Ritonavir (RTV)
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir (RTV) 200 mg QD
Trial: 17088488
Drug: Ritonavir (RTV)
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir (RTV) 100 mg QD
Trial: 3318377
Drug: High-dose carbonyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose carbonyl iron 600 mg three times per day
Trial: 3318377
Drug: Standard ferrous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard ferrous sulfate 60 mg three times per day
Trial: 29967325
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of BC6 and Deceleration Capacity (DC)
Trial: 29967325
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PE and Deceleration Capacity (DC)
Trial: 27079740
Drug: Mizoribine and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizoribine and steroid
Trial: 27079740
Drug: Cyclophosphamide and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide and steroid
Trial: 25840742
Drug: Metoclopramide (dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (dopamine D2-receptor antagonist)
Trial: 17014912
Drug: Occupational therapy‐led
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy‐led lifestyle treatment